Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Biomedix, Inc. — Predicate Candidate Screening

11 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

90 daysmedian FDA review time
194 days90th percentile
11clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K142097SELEC-3 I.V.ADMINISTRATION SETBiomedix, Inc.2014-08-29281
K122281PADNET 2.0Biomedix, Inc.2012-08-29300
K073146PADNET+Biomedix, Inc.2007-11-21130
K050182Q.STEPS BIOMETER G/C DUAL MONITORING SYSTEMBiomedix, Inc.2005-08-091940
K042616BIOMEDIX PADNET LABBiomedix, Inc.2004-10-12190
K033627Q.STEPS BIOMETER G BLOOD GLUCOSE MONITORING SYSTEMBiomedix, Inc.2004-05-211840
K973857FLOSTAT VASCULAR REPORT GENERATOR (VRG)Biomedix, Inc.1997-12-29810
K973644FLOSTAT VASCULAR LABBiomedix, Inc.1997-12-23900
K961928BIOMEDIX I.V. EXTENSION LINE W/ STOPCOCK MODEL B50-102/B51-1Biomedix, Inc.1996-09-161220
K925645SELEC-3Biomedix, Inc.1993-09-273220
K926498ENDOGRIPBiomedix, Inc.1993-04-07990

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda